Figure 4
From: Sorafenib in advanced melanoma: a critical role for pharmacokinetics?
PFS probability according to maximal exposure to sorafenib (AUCmax). Dot line: patients with AUCmax <100 mg l−1 h−1/; solid line: patients with AUCmax⩾100 mg l−1 h−1.
